Market
BSE Prices delayed by 5 minutes... << Prices as on Apr 22, 2026 - 3:59PM >>  ABB India  7586.95 [ 4.58% ] ACC  1445.9 [ 0.55% ] Ambuja Cements  460 [ 0.80% ] Asian Paints  2560.1 [ 0.66% ] Axis Bank  1379.55 [ 0.13% ] Bajaj Auto  9604 [ -1.92% ] Bank of Baroda  282.9 [ -0.42% ] Bharti Airtel  1831.45 [ -1.26% ] Bharat Heavy  333.55 [ 0.26% ] Bharat Petroleum  314.45 [ -1.13% ] Britannia Industries  5728.55 [ -1.91% ] Cipla  1235 [ 0.17% ] Coal India  444 [ 0.20% ] Colgate Palm  2110 [ 0.24% ] Dabur India  460.05 [ 1.68% ] DLF  611 [ 0.54% ] Dr. Reddy's Lab.  1216.6 [ -0.34% ] GAIL (India)  166.15 [ 3.33% ] Grasim Industries  2776.5 [ -0.05% ] HCL Technologies  1285.2 [ -10.85% ] HDFC Bank  799.9 [ -1.45% ] Hero MotoCorp  5192.6 [ -1.30% ] Hindustan Unilever  2368.7 [ 2.75% ] Hindalco Industries  1039.7 [ 1.76% ] ICICI Bank  1367.8 [ -1.50% ] Indian Hotels Co.  659 [ -1.06% ] IndusInd Bank  869.9 [ 1.57% ] Infosys  1268.45 [ -3.40% ] ITC  305.45 [ -1.20% ] Jindal Steel  1276 [ -0.99% ] Kotak Mahindra Bank  377.3 [ -1.10% ] L&T  4022.15 [ -1.32% ] Lupin  2300 [ -0.51% ] Mahi. & Mahi  3150.1 [ -2.99% ] Maruti Suzuki India  13375 [ -0.62% ] MTNL  32.13 [ 0.00% ] Nestle India  1395.7 [ 1.23% ] NIIT  71.24 [ -0.06% ] NMDC  88.57 [ 0.14% ] NTPC  405.55 [ 2.39% ] ONGC  283.7 [ 0.23% ] Punj. NationlBak  114.65 [ 0.48% ] Power Grid Corpn.  319.75 [ 0.14% ] Reliance Industries  1362.9 [ 0.68% ] SBI  1103.4 [ -0.79% ] Vedanta  757.05 [ -1.30% ] Shipping Corpn.  297.7 [ -1.06% ] Sun Pharmaceutical  1669.5 [ 0.26% ] Tata Chemicals  711.35 [ 0.52% ] Tata Consumer  1180.5 [ 3.29% ] Tata Motors Passenge  361.65 [ 1.57% ] Tata Steel  213.05 [ 0.47% ] Tata Power Co.  436.05 [ 0.08% ] Tata Consult. Serv.  2537.55 [ -2.80% ] Tech Mahindra  1462.85 [ -2.50% ] UltraTech Cement  12195 [ 1.35% ] United Spirits  1393.9 [ 2.29% ] Wipro  204.05 [ -0.49% ] Zee Entertainment  87.61 [ 0.99% ] 
Pharmaids Pharmaceuticals Ltd. Auditor Report
Search Company 
You can view full text of the latest Auditor's Report for the company.
Market Cap. (Rs.) 109.26 Cr. P/BV 2.22 Book Value (Rs.) 13.97
52 Week High/Low (Rs.) 73/27 FV/ML 10/1 P/E(X) 0.00
Bookclosure 24/09/2024 EPS (Rs.) 0.00 Div Yield (%) 0.00
Year End :2025-03 

We have audited the Financial Statements of PHARMAIDS PHARMACEUTICALS LIMITED ("the
Company"), which comprise the balance sheet as at 31st March 2025, and the statement of profit and
loss including other comprehensive income, statement of changes in equity and statement of cash
flows for the period ended, and notes to the Financial Statements, including a summary of significant
accounting policies and other explanatory information [hereinafter referred to as "the Financial
Statements"].

In our opinion and to the best of our information and according to the explanations given to us, the
aforesaid Financial Statements give the information required by the Companies Act, 2013 in the
manner so required and give a true and fair view in conformity with the accounting principles generally
accepted in India, of the state of affairs of the Company as at March 31, 2025, its Loss including other
comprehensive income, changes in equity and its cash flows for the year ended on that date.

Basis for Opinion

We conducted our audit of the Financial Statements in accordance with the Standards on Auditing
(SAs) specified under section 143(10) of the Companies Act, 2013. Our responsibilities under those
Standards are further described in the
Auditor's Responsibilities for the Audit of the Financial
Statements
section of our report. We are independent of the Company in accordance with the Code
of Ethics
issued by the Institute of Chartered Accountants of India together with the ethical
requirements that are relevant to our audit of the Financial Statements under the provisions of the
Companies Act, 2013 and the Rules thereunder, and we have fulfilled our other ethical responsibilities
in accordance with these requirements and the Code of Ethics. We believe that the audit evidence we
have obtained is sufficient and appropriate to provide a basis for our opinion on the standalone
financial statements.

"Information Other than the Financial Statements and Auditor's Report Thereon"

The Company's Board of Directors is responsible for the other information. The other information
comprises the information included in the Annual report, but does not include the Financial
Statements and our auditor's report thereon.

Our opinion on the Financial Statements does not cover the other information and we do not express
any form of assurance or conclusion thereon.

In connection with our audit of the Financial Statements, our responsibility is to read the other
information and, in doing so, consider whether the other information is materially inconsistent with
the Financial Statements or our knowledge obtained in the audit or otherwise appears to be materially
misstated.

If, based on the work we have performed, we conclude that there is a material misstatement of this
other information, we are required to report that fact. We have nothing to report in this regard.

Emphasis of Matter

We draw attention to Note 34 of the standalone financial statements, which describes a non-adjusting
subsequent event that occurred after the Balance sheet date 31st March 2025. The Board of Directors
of the Company, at its meeting held on 04 July 2025, approved the disinvestment of the Company's
entire 66.50% partnership stake in Anugraha Chemicals. In accordance with the applicable provisions
of the Companies Act, 2013 and SEBI Listing Regulations, shareholders' approval is also being sought
through a Postal Ballot Notice dated 04 July 2025. The e-voting process through postal ballot concluded
on August 14, 2025, with a majority of shareholders voting in favor of the proposal, thereby granting
approval.

As approved in the resolution passed by the Board, the company entered into an enabling agreement
with Anugraha Chemicals on 10 July 2025, to sell the stake to Mr. Sourabh Hadimani (existing partner)
or his nominee subject to receipt of shareholders' approval.

This transaction occurred after the reporting date of 31st March 2025 and is classified as a non¬
adjusting subsequent event under Ind AS 10. As such, the financial statements for the year ended 31st
March 2025 have not been adjusted for this event. However, it has been disclosed in this report to
provide stakeholders with relevant information regarding the Company's ongoing activities.

The Company's management believes that this event does not affect the financial position or
performance for the year ended 31st March 2025.

Management's Responsibility for the Standalone Financial Statements

The Company's Board of Directors is responsible for the matters stated in section 134(5) of the
Companies Act, 2013 ("the Act") with respect to the preparation of these Standalone Financial
Statements that give a true and fair view of the financial position and financial performance including
other comprehensive income, changes in equity and cash flows of the Company in accordance with
the accounting principles generally accepted in India, including the Indian Accounting Standards (Ind
AS) specified under section 133 of the Act. This responsibility also includes maintenance of adequate
accounting records in accordance with the provisions of the Act for safeguarding of the assets of the
Company and for preventing and detecting frauds and other irregularities; selection and application of
appropriate accounting policies; making judgments and estimates that are reasonable and prudent;
and design, implementation and maintenance of adequate internal financial controls, that were
operating effectively for ensuring the accuracy and completeness of the accounting records, relevant
to the preparation and presentation of the Standalone Financial Statements that give a true and fair
view and are free from material misstatement, whether due to fraud or error.

In preparing the Standalone Financial Statements, the Board of Directors is responsible for assessing
the Company's ability to continue as a going concern, disclosing, as applicable, matters related to going
concern and using the going concern basis of accounting unless the Board of Directors either intends
to liquidate the Company or to cease operations, or has no realistic alternative but to do so.

Those Board of Directors are also responsible for overseeing the Company's financial reporting
process.

Auditor's Responsibilities for the Audit of the Standalone Financial Statements

Our objectives are to obtain reasonable assurance about whether the Standalone Financial Statements
as a whole are free from material misstatement, whether due to fraud or error, and to issue an
auditor's report that includes our opinion. Reasonable assurance is a high level of assurance, but is not
a guarantee that an audit conducted in accordance with SAs will always detect a material misstatement
when it exists. Misstatements can arise from fraud or error and are considered material if, individually
or in the aggregate, they could reasonably be expected to influence the economic decisions of users

taken on the basis of these Standalone Financial Statements.

As part of an audit in accordance with SAs, we exercise professional judgment and maintain
professional skepticism throughout the audit. We also:

A. Identify and assess the risks of material misstatement of the Financial Statements, whether due to
fraud or error, design and perform audit procedures responsive to those risks, and obtain audit
evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not
detecting a material misstatement resulting from fraud is higher than for one resulting from error,
as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override
of internal control.

B. Obtain an understanding of internal control relevant to the audit in order to design audit
procedures that are appropriate in the circumstances. Under section 143(3)(i) of the Companies
Act, 2013, we are also responsible for expressing our opinion on whether the company has
adequate internal financial controls system in place and the operating effectiveness of such
controls.

C. Evaluate the appropriateness of accounting policies used and the reasonableness of accounting
estimates and related disclosures made by management.

D. Conclude on the appropriateness of management's use of the going concern basis of accounting
and, based on the audit evidence obtained, whether a material uncertainty exists related to events
or conditions that may cast significant doubt on the Company's ability to continue as a going
concern. If we conclude that a material uncertainty exists, we are required to draw attention in
our auditor's report to the related disclosures in the Standalone Financial Statements or, if such
disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit
evidence obtained up to the date of our auditor's report. However, future events or conditions
may cause the Company to cease to continue as a going concern.

E. Evaluate the overall presentation, structure and content of the Standalone Financial Statements,
including the disclosures, and whether the Standalone Financial Statements represent the
underlying transactions and events in a manner that achieves fair presentation

Materiality is the magnitude of misstatements in the Standalone Financial Statements that, individually
or in aggregate, makes it probable that the economic decisions of a reasonably knowledgeable user of
the Financial Statements may be influenced. We consider quantitative materiality and qualitative
factors in

(i) Planning the scope of our audit work and in evaluating the results of our work; and

(ii) to evaluate the effect of any identified misstatements in the Standalone Financial
Statements.

We communicate with those charged with governance regarding, among other matters, the planned
scope and timing of the audit and significant audit findings, including any significant deficiencies in
internal control that we identify during our audit.

We also provide those charged with governance with a statement that we have complied with relevant
ethical requirements regarding independence, and to communicate with them all relationships and
other matters that may reasonably be thought to bear on our independence, and where applicable,
related safeguards.

From the matters communicated with those charged with governance, we determine those matters
that were of most significance in the audit of the Standalone Financial Statements of the current period
and are therefore the key audit matters. We describe these matters in our auditor's report unless law
or regulation precludes public disclosure about the matter or when, in extremely rare circumstances,
we determine that a matter should not be communicated in our report because the adverse

consequences of doing so would reasonably be expected to outweigh the public interest benefits of
such communication.

Report on Other Legal and Regulatory Requirements

1. As required by the Companies (Auditor's Report) Order, 2020 ("the Order"), issued by the Central
Government of India in terms of sub-section (11) of section 143 of the Companies Act, 2013, we
give in the Annexure A statement on the matters specified in paragraphs 3 and 4 of the Order, to
the extent applicable.

2. As required by Section 143(3) of the Act, we report that:

(a) We have sought and obtained all the information and explanations which to the best of our
knowledge and belief were necessary for the purposes of our audit.

(b) In our opinion, proper books of account as required by law have been kept by the Company
so far as it appears from our examination of those books

(c) The Balance Sheet, the Statement of Profit and Loss including statement of other
comprehensive income, the Statement of Changes in Equity and the Cash Flow statements
dealt with by this Report are in agreement with the books of account.

(d) In our opinion, the aforesaid Standalone Financial Statements comply with the Accounting
Standards specified under Section 133 of the Act, read with Companies (Indian Accounting
Standards) Rules, 2015, as amended.

(e) On the basis of the written representations received from the directors as on 31st March,
2025 taken on record by the Board of Directors, none of the directors is disqualified as on
31st March, 2025 from being appointed as a director in terms of Section 164(2) of the Act.

(f) According to information and explanations given to us together with our audit examination,
reporting with respect to the adequacy of the internal financial controls over financial
reporting of the Company and the operating effectiveness of such controls we give in
Annexure B to the extent applicable.

(g) With respect to the other matters to be included in the Auditor's Report in accordance with
Rule 11 of the Companies (Audit and Auditors) Rules, 2014, in our opinion and to the best of
our information and according to the explanations given to us:

I. The Company does not have any pending litigations which would impact its financial
position.

II. The Company did not have any long-term contracts including derivative contracts for
which there were any material foreseeable losses.

III. There were no amounts which were required to be transferred to the Investor
Education and Protection Fund by the Company

IV.

1) The management has represented that, to the best of its knowledge and belief,
no funds (which are material either individually or in the aggregate)have been
advanced or loaned or invested (either from borrowed funds or share premium
or any other sources or kind of funds) by the company to or in any other person(s)
or entity(ies), including foreign entities ("Intermediaries"), with the

understanding, whether recorded in writing or otherwise, that the Intermediary
shall, whether, directly or indirectly lend or invest in other persons or entities
identified in any manner whatsoever by or on behalf of the company ("Ultimate
Beneficiaries") or provide any guarantee, security or the like on behalf of the
Ultimate Beneficiaries;

2) The management has represented, that, to the best of its knowledge and belief,
no funds ((which are material either individually or in the aggregate)have been
received by the company from any person(s) or entity(ies), including foreign
entities ("Funding Parties"), with the understanding, whether recorded in writing
or otherwise, that the company shall, whether, directly or indirectly, lend or invest
in other persons or entities identified in any manner whatsoever by or on behalf
of the Funding Party ("Ultimate Beneficiaries") or provide any guarantee, security
or the like on behalf of the Ultimate Beneficiaries; and

3) Based on such audit procedures that the auditor has considered reasonable and
appropriate in the circumstances, nothing has come to their notice that has
caused them to believe that the representations under sub-clause (i) and (ii)
contain any material mis-statement.

V. No Dividend has been declared or paid during the year by the company, hence
provisions of section 123 of the Companies Act, 2013, are not applicable.

VI. Based on our examination, which included test checks, the Company has used
accounting software for maintaining its books of account for the financial year ended
March 31, 2025 which has a feature of recording audit trail (edit log) facility and the
same has operated throughout the year for all relevant transactions recorded in the
software. Further, during the course of our audit we did not come across any instance
of the audit trail feature being tampered with.

For PPKG & Co

Chartered Accountants

Firm's Registration No: 0096555

CA Girdhari Lal Toshniwal

Partner

Membership No: 205140

UDIN: 25205140BMOPDT2067

Place: Hyderabad

Date: 21-08-2025


 
KYC IS ONE TIME EXERCISE WHILE DEALING IN SECURITIES MARKETS - ONCE KYC IS DONE THROUGH A SEBI REGISTERED INTERMEDIARY (BROKER, DP, MUTUAL FUND ETC.), YOU NEED NOT UNDERGO THE SAME PROCESS AGAIN WHEN YOU APPROACH ANOTHER INTERMEDIARY. | PREVENT UNAUTHORISED TRANSACTIONS IN YOUR ACCOUNT --> UPDATE YOUR MOBILE NUMBERS/EMAIL IDS WITH YOUR STOCK BROKER/DEPOSITORY PARTICIPANT. RECEIVE INFORMATION/ALERT OF YOUR TRANSACTIONS DIRECTLY FROM EXCHANGE/NSDL ON YOUR MOBILE/EMAIL AT THE END OF THE DAY .......... ISSUED IN THE INTEREST OF INVESTORS
Disclaimer Clause | Privacy | Terms of Use | Rules and regulations | Feedback| IG Redressal Mechanism | Investor Charter | Client Bank Accounts
Right and Obligation, RDD, Guidance Note in Vernacular Language
Attention Investors : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."
  "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
  "Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participants. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL on the same day.Issued in the interest of Investors."
Regd. Office: 76-77, Scindia House, 1st Floor, Janpath, Connaught Place, New Delhi – 110001
NSE CASH , NSE F&O,NSE CDS| BSE CASH ,BSE CDS |DP NSDL | MCX-SX SEBI NO: INZ000155732

Compliance Officer: Mukesh Rustagi, Company Secretary, Tel: 011-46890000, Email: mukesh_rustagi80@hotmail.com
For grievances please e-mail at: kkslig@hotmail.com

Important Links : NSE | BSE | SEBI | NSDL | Speed-e | CDSL | SCORES | NSDL E-voting | CDSL E-voting
 
Charts are powered by TradingView.
Copyrights @ 2014 © KK Securities Limited. All Right Reserved
Designed, developed and content provided by